The best way to leverage trust is by earning it. This comes with time. Since the company’s founding over three decades ago, its pioneering research has shaped vaccine development by underpinning many promising experimental and therapeutic approaches. This coincides with the interest in KLH for immunological study.
As early as 1942, the benefits of keyhole limpet hemocyanin (KLH) were being mentioned in the likes of JAMA, the Journal of the American Medical Association. For scores of years, KLH has been used to measure immune function, while its subunits in aqueous solution in formulations like VACMUNE are deployed to carry advanced vaccines to their target sites. Major drug makers appreciate the high pharmaceutical quality supplied by biosyn’s GMP manufacturing. The long history of successful outcomes achieved with IMMUCOTHEL for bladder cancer recurrence dates back over 20 years. The fact that such patients directly ask to be treated with biosyn’s low-side effect KLH therapeutic is further tribute to the nature of these long-standing relationships. To read more about the science behind these products, download or order biosyn’s new folder: